BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis and biological evaluation of pyrazolo[3,4-b]pyridine derivatives as TRK inhibitors. 2023

Nian Liu, and Xin Wang, and Qinglin Fu, and Qiaohua Qin, and Tianxiao Wu, and Ruicheng Lv, and Dongmei Zhao, and Maosheng Cheng
Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University 103 Wenhua Road, Shenhe District Shenyang 110016 PR China.

Tropomyosin receptor kinases (TRKs) are associated with the proliferation and differentiation of cells, and thus their continuous activation and overexpression cause cancer. Herein, based on scaffold hopping and computer-aid drug design, 38 pyrazolo[3,4-b]pyridine derivatives were synthesised. Further, we evaluated their activities to inhibit TRKA. Among them, compound C03 showed acceptable activity with an IC50 value of 56 nM and it inhibited the proliferation of the Km-12 cell line with an IC50 value of 0.304 μM together with obvious selectivity for the MCF-7 cell line and HUVEC cell line. Furthermore, compound C03 possessed good plasma stability and low inhibitory activity to a panel of cytochrome P450 isoforms except CYP2C9. Overall, C03 has potential for further exploration.

UI MeSH Term Description Entries

Related Publications

Nian Liu, and Xin Wang, and Qinglin Fu, and Qiaohua Qin, and Tianxiao Wu, and Ruicheng Lv, and Dongmei Zhao, and Maosheng Cheng
Synthesis and biological evaluation of 3,6-diamino-1H-pyrazolo[3,4-b]pyridine derivatives as protein kinase inhibitors.
August 2009, Bioorganic & medicinal chemistry letters,
Nian Liu, and Xin Wang, and Qinglin Fu, and Qiaohua Qin, and Tianxiao Wu, and Ruicheng Lv, and Dongmei Zhao, and Maosheng Cheng
Design, synthesis, molecular modeling and biological evaluation of novel 1H-pyrazolo[3,4-b]pyridine derivatives as potential anticancer agents.
August 2016, Bioorganic chemistry,
Nian Liu, and Xin Wang, and Qinglin Fu, and Qiaohua Qin, and Tianxiao Wu, and Ruicheng Lv, and Dongmei Zhao, and Maosheng Cheng
Design, synthesis and biological evaluation of macrocyclic derivatives as TRK inhibitors.
December 2021, Bioorganic & medicinal chemistry letters,
Nian Liu, and Xin Wang, and Qinglin Fu, and Qiaohua Qin, and Tianxiao Wu, and Ruicheng Lv, and Dongmei Zhao, and Maosheng Cheng
Synthesis of novel 1H-Pyrazolo[3,4-b]pyridine derivatives as DYRK 1A/1B inhibitors.
September 2021, Bioorganic & medicinal chemistry letters,
Nian Liu, and Xin Wang, and Qinglin Fu, and Qiaohua Qin, and Tianxiao Wu, and Ruicheng Lv, and Dongmei Zhao, and Maosheng Cheng
Synthesis and evaluation of pyrazolo[3,4-b]pyridine CDK1 inhibitors as anti-tumor agents.
August 2007, Bioorganic & medicinal chemistry letters,
Nian Liu, and Xin Wang, and Qinglin Fu, and Qiaohua Qin, and Tianxiao Wu, and Ruicheng Lv, and Dongmei Zhao, and Maosheng Cheng
Pyrazolo[1,5-a]pyrimidine based Trk inhibitors: Design, synthesis, biological activity evaluation.
January 2021, Bioorganic & medicinal chemistry letters,
Nian Liu, and Xin Wang, and Qinglin Fu, and Qiaohua Qin, and Tianxiao Wu, and Ruicheng Lv, and Dongmei Zhao, and Maosheng Cheng
Synthesis and biological activity of new potential antimalarial: 1H-pyrazolo[3,4-b]pyridine derivatives.
January 2000, Bollettino chimico farmaceutico,
Nian Liu, and Xin Wang, and Qinglin Fu, and Qiaohua Qin, and Tianxiao Wu, and Ruicheng Lv, and Dongmei Zhao, and Maosheng Cheng
Identification of 1H-pyrazolo[3,4-b]pyridine derivatives as potent ALK-L1196M inhibitors.
December 2019, Journal of enzyme inhibition and medicinal chemistry,
Nian Liu, and Xin Wang, and Qinglin Fu, and Qiaohua Qin, and Tianxiao Wu, and Ruicheng Lv, and Dongmei Zhao, and Maosheng Cheng
Synthesis and biological evaluation of xanthine oxidase inhibitors. Pyrazolo(3,4-d)pyrimidines and pyrazolo(3,4-b)pyridines.
February 1975, Journal of medicinal chemistry,
Nian Liu, and Xin Wang, and Qinglin Fu, and Qiaohua Qin, and Tianxiao Wu, and Ruicheng Lv, and Dongmei Zhao, and Maosheng Cheng
Synthesis and biological evaluation of novel alkyl amide functionalized trifluoromethyl substituted pyrazolo[3,4-b]pyridine derivatives as potential anticancer agents.
November 2013, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!